News | News By Subject | News by Disease News By Date | Search News

Pancreatitis News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (LLY)'s Tradjenta and Jentadueto Labeling to Reflect Pancreatitis Risk     6/21/2013
Isis Pharmaceuticals, Inc. (ISIS)'s apoC-III Shown to Significantly Reduce Triglycerides     4/1/2013
Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK) Diabetes Drugs Linked to Pancreatitis Risk     2/28/2013
Novartis AG (NVS) Gains FDA Approval for Afinitor(R) as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET     5/6/2011
FDA, European Medicines Evaluation Agency to Re-analyze Repligen Corporation (RGEN)'s Late-Stage Data     5/27/2010
Eurand Granted FDA Approval for ZENPEP(TM)     8/28/2009
Solvay Pharmaceuticals, Inc.'s CREON(R) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines     5/1/2009
Eurand (Milan, Italy) (EURX) Granted Priority Review for Zentase NDA     2/21/2008
Novo Nordisk A/S (NVO) Says No Signs Liraglutide Causes Pancreatitis     10/17/2007
Amylin Pharmaceuticals, Inc. (AMLN)'s Byetta Will Add Warning About Pancreas Risk     10/16/2007
Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)     8/20/2007
Novozymes A/S And Solvay Pharmaceuticals, Inc. To Collaborate On Digestive Enzymes     11/8/2004

News from Around the Web

Press Releases
AzurRx BioPharma (AZRX) Reaches 6th Patient Enrollment Of Phase IIa Trial Of MS1819 For Treatment Of Exocrine Pancreatic Insufficiency Associated With Chronic Pancreatitis     8/23/2017
ChiRhoClin Release: ChiRhoStim (Human Secretin For Injection) ChiRhoClin Approved Labeling Update And 5-Year Shelf Life Approval     7/25/2017
CalciMedica Receives Fast-Track Designation For CM4620, A Novel CRAC Channel Inhibitor To Treat Acute Pancreatitis     5/25/2017
Zealand Pharma  (ZEAL.CO) Release: Positive Phase IIa Results With Microdoses Of Dasiglucagon Support Use In A Dual-Hormone Artificial Pancreas System     5/23/2017
Seattle Children's Hospital Release: Research Links Genetics To Early-Onset Pancreatitis In Pediatric Patients     5/11/2017
AzurRx Provides Update On MS1819 Phase II Trial     4/11/2017
CalciMedica Initiates Phase 1 Clinical Studies For CRAC Channel Inhibitor     1/6/2017
Zealand Pharma  (ZEAL.CO) Initiates Phase IIa Clinical Trial With Dasiglucagon In A Dual-Hormone Artificial Pancreas System From Beta Bionics     12/13/2016
Celprogen Introduces 3D Printed Human Pancreas That May Someday Be Utilized In Pancreatic Transplants     12/1/2016
Araim Pharmaeuticals Release: ARA 290 Obtains European Union Orphan Drug Designation For Prevention Of Graft Loss In Pancreatic Islet Transplantation     11/28/2016
AzurRx BioPharma (AZRX) And Mayoly Spindler Announce Initiation Of Phase II Clinical Trial Of MS1819-SD For Exocrine Pancreatic Insufficiency In Chronic Pancreatitis Patients     11/17/2016
Mauna Kea Technologies Release: Cellvizio's Strong Clinical Efficacy In The Prevention Of Certain Pancreatic Cancers Confirmed By Positive Results From Contact Study Presented At UEGW 2016     10/19/2016
Medtronic (MDT) Offers Assurances as Analysts Question Timeline for Artificial Pancreas     8/26/2016
Tandem Diabetes Care And Typezero Technologies Announce License Agreement To Accelerate Development And Commercialization Of Closed-Loop Artificial Pancreas System     7/21/2016
Anthera Provides Clinical Program Updates For Blisibimod And Sollpura     6/29/2016

//-->